Acute Promyelocytic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Promyelocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia [Phase 2]
Phase 2 clinical trial evaluating chemotherapy plus a monoclonal antibody in patients with acute promyelocytic leukemia has been completed.
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes [Phase 1]
This Phase 1 trial evaluated SB-715992 in adults with various acute leukemias, chronic myeloid leukemia in blast phase, and advanced myelody…
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia [Phase 4]
This entry provides an update on the AIDA2000 Phase 4 trial evaluating risk-adapted therapy for acute promyelocytic leukemia.
-
FDA approval · 2010-07-23FDA Approved: TRISENOX — Supplemental Application (Cephalon, LLC)
FDA approves a supplemental application for TRISENOX (arsenic trioxide) submitted by Cephalon, LLC.
-
CLINICAL_TRIALS trial_result · 2009-08-20Clinical Trial Update: Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission [Phase 3]
Phase 3 clinical trial comparing two treatments in intermediate- and high-risk acute promyelocytic leukemia to assess efficacy in achieving …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2008-05-12Clinical Trial Update: Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia [Phase 2]
This clinical trial update describes a Phase 2 study of NRX 195183 in patients with relapsed or refractory acute promyelocytic leukemia; the…
-
CLINICAL_TRIALS trial_result · 2008-03-31Clinical Trial Update: Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) [Phase 4]
A Phase 4 trial evaluates the AIDA regimen (all-trans retinoic acid plus idarubicin) for treating acute promyelocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2008-01-24Clinical Trial Update: APL93: Timing of CxT and Role of Maintenance [Phase 3]
A Phase 3 trial (APL93) evaluated the timing of consolidation therapy and the role of maintenance in acute promyelocytic leukemia; the study…
-
CLINICAL_TRIALS trial_result · 2008-01-14Clinical Trial Update: A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL) [Phase 3]
A Phase 3 randomized trial evaluating the role of cytarabine (Ara-C) in newly diagnosed acute promyelocytic leukemia (APL) has completed.
-
CLINICAL_TRIALS research · 2007-10-23Clinical Trial Update: Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic [Phase 4]
This clinical trial update describes a Phase 4 treatment protocol using arsenic trioxide for relapsed or refractory acute promyelocytic leuk…
-
CLINICAL_TRIALS trial_result · 2007-08-17Clinical Trial Update: Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia [Phase 2, Phase 3]
This document provides an update on a clinical trial evaluating arsenic trioxide as a single-agent treatment for newly diagnosed acute promy…
-
FDA label_change · 2007-04-20FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for tretinoin from Padagis US LLC, resulting in updated labeling.
-
FDA approval · 2007-02-21FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for tretinoin from Padagis US LLC, indicating an update to an existing product's labeling or man…
-
FDA approval · 2007-02-21FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for tretinoin by Padagis US LLC, authorizing changes to the approved generic product.
-
FDA approval · 2007-02-21FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for tretinoin submitted by Padagis US LLC, authorizing changes to the product's labeling under A…